Sepsis inflammation accelerates myeloid cell generation to compensate for rapid mobilization of the myeloid progenitors from bone marrow. This inflammation-driven myelopoiesis, however, generates myeloid progenitors with immunosuppressive functions that are unable to differentiate into mature, innate immune cells. The myeloid-derived suppressor cells (MDSCs) expand markedly in the later phases of sepsis, suppress both innate and adaptive immunity, and thus, elevate mortality. Using a murine model with myeloid-restricted deletion of the C/EBPb transcription factor, we show that sepsis-induced generation of MDSCs depends on C/EBPb. C/EBPb myeloid cell-deficient mice did not generate MDSCs or develop immunosuppression and survived sepsis. However, septic mice still generated Gr1 + CD11b + myeloid progenitors at the steady-state levels similar to the control sham mice, suggesting that C/EBPb is not involved in healthy, steady-state myelopoiesis. C/EBPb-deficient Gr1 + CD11b + cells generated fewer monocyte-and granulocyte-like colonies than control mice did, indicating reduced proliferation potential, but differentiated normally in response to growth factors. Adoptive transfer of C/EBPb-deficient Gr1 + CD11b + cells from late septic mice exacerbated inflammation in control mice undergoing early sepsis, confirming they were not immunosuppressive. These results show that C/EBPb directs a switch from proinflammatory to repressor myeloid cells and identifies a novel treatment target.
Introduction
A hyperinflammatory reaction to infection initiates highly lethal sepsis [1, 2] . This early hyperinflammatory state follows excessive production of proinflammatory cytokines, such as TNF-a and IL-6 [3, 4] . Although this proinflammatory phase predominates during the early sepsis response, recent reports of gene expression in animals and human sepsis provide evidence that an opposing anti-inflammatory response occurs concomitantly and dominates during a profoundly immunorepressed and catabolic state with continued organ dysfunction [5] [6] [7] . Sepsis-induced immunosuppression increases production of immunosuppressive soluble mediators, depletion of T cells and dendritic cells by increased apoptosis, immune exhaustion with paralysis of CD8 + T cell effector properties, and fosters bacterial growth [8, 9] . Sepsis immunosuppression prolongs the primary microbial infection and increases the risk of opportunistic infections and organ dysfunctions and predicts poor outcome [1, 10, 11] . Earlier attempts to treat human sepsis by reducing the early/ acute hyperinflammatory reaction uniformly failed, mainly because of the rapid shift of sepsis immune responses from immune activation to immune suppression [12, 13] . Thus, understanding how sepsis promotes the shift from effector to repressor immune phenotypes is critical for designing a treatment presently unavailable to septic humans.
We [14] and others [15, 16] have reported increased generation and expansion of MDSCs in mice during sepsis. These immature myeloid cells include progenitors and precursors of monocyte, granulocyte, and dendritic cells; express the myeloid differentiation markers Gr1 and CD11b; and are immunosuppressive [17, 18] . MDSCs accumulate in peripheral blood of patients with sepsis [19] and the bone marrow and spleens of septic mice [14, 15] . Our studies in a mouse polymicrobial sepsis model, which uses limited antibiotic treatment to promote a chronic immunosuppressive state, show progressive increases in Gr1 + CD11b + MDSCs in the late sepsis phase because of failure of the Gr1 + CD11b + myeloid progenitors to differentiate into immunocompetent, innate immune cells [14] . We identified expression of miR-21 and miR-181b as promoting expansion of Gr1 +
CD11b
+ repressor cells after sepsis onset, and our results also implicated myeloid differentiation transcription factor NFI-A, which activates NF-kB, in attenuating differentiation of the Gr1 + CD11b
+ cells [20, 21] . Importantly, in vivo blockade of miR-21 and miR-181b with specific antagomirs prevented MDSC generation [20] , whereas ex vivo knockdown of NFI-A in Gr1 + CD11b + cells enhanced their differentiation and maturation [21] . We also showed that C/EBPBb induces miR-21 and miR-181 in Gr1 + CD11b + cells during sepsis [22] . We found that nuclear C/EBPb and Stat3 bind to, and activate, miR-21 and miR-181b promoters in sepsis but not naive, Gr1
+ CD11b + cells [22] . In vitro knockdown of C/EBPb inhibited miR-21 and miR181b expression in bone marrow Gr1 + CD11b + cells from septic mice [22] . C/EBPb promotes inflammation-induced myelopoiesis, but its role in sepsis immunosuppression is unknown [23] .
Here, we investigated the role of C/EBPb in sepsis-induced generation and expansion of Gr1 +
+ MDSCs, using mice with a conditional deletion of the Cebpb allele in the myeloid lineage. We find that C/EBPb-deficient, septic mice were unable to generate MDSCs but still generated healthy Gr1 + CD11b + cells, which supports sepsis survival in the absence of MDSCs. We conclude that myeloid cell C/EBPb controls the polymicrobial sepsis outcome in mice by promoting immunosuppression.
MATERIALS AND METHODS

Production of BALB/cJ Cebpb-floxed mice
The BALB/cJ Cebpb-floxed allele was created by gene targeting in BALB/cJ embryonic stem cells (PRX-Balb/cJ 9; Primogenix Biological Laboratories, Laurie, MO, USA) with a gene-targeting vector described by Sterneck et al. [24] . The Cebpb targeting event inserted a loxP site 227 bp 59 of the Cebpb transcriptional start site and a loxP-flanked neomycin-resistance cassette 228 bp 39 of the Cebpb polyadenylation site (Supplemental Fig. 1 ). Targeted embryonic stem cells were initially identified by long-range PCR with 1 primer outside the vector homology arm and a second primer in the inserted sequence. PCR-positive clones were validated by Southern blot analysis using 59 and 39 probes external to the vector homology arms and with a neomycin internal probe. A single, correctly targeted clone (2B) was electroporated with a Cre expression plasmid, and subclones were screened by PCR for removal of the neomycin cassette and retention of the Cebpb coding sequence. Three subclones were injected into C57BL/6 blastocysts to generate chimeras, which were mated to BALB/cJ females for germline transmission of the Cebpb-floxed allele.
Production of BALB/cJ Lyz2-Cre knock-in mice
The construction of the BALB/cJ-Lyz2
Cre knock-in allele was similar to the allele described by Clausen et al. [25] and is shown in Supplemental Fig. 2 .
Generation of BALB/cJ Cebpb cKO mice
The myeloid-specific C/EBPb knockout mice were generated by breeding the above-described Cebpb-floxed mice with the Lyz2 Cre knock-in mice. 
Sepsis
Polymicrobial sepsis was induced by CLP in 8-10-wk-old mice. We used a 21-gauge needle and 2 punctures, followed by antibiotic [imipenem (Merck, White House Station, NJ, USA); 25 mg/kg body weight] administration to generate early/acute and late/chronic septic phases, as described previously [26] . Mice were s.c. administered antibiotic or an equivalent volume of 0.9% saline. This model creates a prolonged infection with 100% mortality over 4 wk. To establish intra-abdominal infection and approximate the clinical situation of early human sepsis, in which there often is a delay between the onset of sepsis and the delivery of therapy [27] , injections of imipenem were given at 8 and 16 h after CLP, which resulted in high mortality (;60-70%) during the late/chronic phase [26] . The presence of early sepsis was confirmed by transient, systemic bacteremia and elevated cytokine levels in the first 5 d after CLP. Late/chronic sepsis (after d 5) was confirmed by enhanced peritoneal bacterial overgrowth and reduced circulating levels of the proinflammatory cytokines TNF-a and IL-6.
We used male mice because several clinical and experimental studies have shown that cell-mediated immune responses are depressed in males with sepsis, whereas they are unchanged or enhanced in females [28, 29] . In addition, previous studies using CLP model provided evidence that female mice are more immunologically competent than male mice in surviving this insult [30] . Because MDSCs suppress both innate and adaptive immune responses, we used male mice so we could assess the maximal effect of this immunosuppressive cell population on sepsis outcome.
Bacterial culture
Immediately after mice were euthanized, the peritoneal cavity was lavaged with 5 ml PBS. The lavage was cleared by centrifugation. Blood was collected via cardiac puncture in heparinized tubes. Lavage or blood was plated on trypticase soy agar base (BD Biosciences, Sparks, MD, USA). The plates were incubated for 24 h at 37°C under aerobic conditions. The plates were read by a microbiologist, and the CFUs were determined. 
Gr1
Colony-forming cell assay
Bone marrow Gr1 
Flow cytometry
Freshly isolated or differentiated Gr1 + CD11b + cells were stained by incubation for 30 min on ice in staining buffer (PBS plus 2% FBS) with the following Abs: anti-Gr1 conjugated to FITC, anti-CD11b conjugated to PE, anti-Ly6G conjugated to allophycocyanin, anti-Ly6C conjugated to FITC, anti-F4/80 conjugated to allophycocyanin, anti-CD11c conjugated to PE, and anti-MHC II conjugated to FITC. CD4 + T cells were stained with anti-CD4 conjugated to PE (all Abs were from eBioscience). An appropriate, isotype-matched control was used for each Ab. After washing, the samples were analyzed by a FACSCaliber flow cytometer (BD Biosciences). About 25,000 events were acquired and analyzed using the CellQuest Pro software (BD Biosciences).
Cytokine measurements
Cytokine concentrations in blood or culture supernatants were determined using specific ELISA kits (eBioscience) according to the manufacturer's instructions. Each sample was run in duplicate.
Transfection of miRNA precursors
Cells were transfected using HiPerFect transfection reagent per the manufacturer's instructions (Qiagen, Germantown, MD, USA). For miR-21 and miR-181b expression, Gr1 
Quantitative real-time PCR
The levels of miR-21 and miR-181b in Gr1 + CD11b + cells were determined by quantitative real-time PCR using miRNA-enriched RNA and miScript Primer Assays specific to miR-21 and miR-181b according to the manufacturer's instructions (Qiagen). PCR reactions were run in duplicate at 95°C for 10 min followed by 40 cycles at 95°C for 15 s and 60°C for 1 min using the iCycler iQ5 detection system (Bio-Rad Laboratories, Hercules, CA, USA). The relative expression of each miRNA was calculated using the 2 2ΔΔCt cycle threshold method after normalization to the endogenous U6 RNA as an internal control.
Western blotting
Equal amounts of protein extracts were mixed with 5X Laemmli sample buffer, separated by a SDS-10% polyacrylamide gel (Bio-Rad Laboratories) and subsequently transferred to nitrocellulose membranes (Thermo Fisher Scientific). After blocking with 5% milk in Tris-buffered saline/Tween-20 for 1 h at room temperature, membranes were probed overnight at 4°C with mouse anti-C/EBPb Ab (Santa Cruz Biotechnology, Dallas, TX, USA). After washing, blots were incubated with an HRP-conjugated secondary Ab (Thermo Fisher Scientific) for 2 h at room temperature. Proteins were detected with the enhanced chemiluminescence detection system (Thermo Fisher Scientific). The developed bands were visualized using the ChemiDoc XRS System (Bio-Rad Laboratories), and the images were captured with the Image Lab Software V3.0 (Bio-Rad Laboratories). Membranes were stripped and reprobed with b-actin Ab (Sigma-Aldrich, St. Louis, MO, USA).
Statistical analysis
The Kaplan-Meier survival curve was plotted by use of a GraphPad Prism version 5.0 (GraphPad Software, La Jolla, CA, USA), and survival significance was determined by a log-rank test. Other data were analyzed by Microsoft (Redmond, WA, USA) Excel, version 3.0. Data are expressed as means 6 SD. Differences among groups were analyzed by Student's t test. Statistical significance was set at P , 0.05.
RESULTS
C/EBPb cKO model
Female mice with conventional C/EBPb knockout are sterile because the ovary lacks the corpora lutea [24] . Therefore, to investigate the effects of C/EBPb on Gr1 + CD11b + generation and expansion in sepsis, we generated a C/EBPb cKO mouse model, in which the Cebpb allele was floxed and then deleted in all myeloid lineage cells by crossing to the deleter strain Lyz2
Cre (Supplemental Fig. 1 ). Genotyping PCR showed inactivation of the Cebpb allele in bone marrow Gr1 + CD11b
+ cells but not in tail tissue (Supplemental Fig. 1C ). Western blot analysis confirmed that Gr1 + CD11b + cells were negative for Cebpb expression (Supplemental Fig. 1D ). Note C/EBPb protein is induced only after sepsis initiation [20] . The myeloid-specific deletion of the Cebpb allele did not result in any phenotypic abnormalities because these mice exhibited normal development, growth, and survival.
Myeloid-specific C/EBPb deficiency reduces sepsis mortality significantly
To examine the effects of myeloid-specific Cebpb inactivation on sepsis pathogenesis, we used a polymicrobial sepsis model that emulates general peritonitis in humans [31] by administering limited antibiotic treatment during the first 24 h [26] . The results showed that C/EBPb deficiency does not alter mortality during the early phase (Fig. 1A) , but in the late sepsis phase, it increased survival by 80% compared with the control mice that express C/EBPb in the Gr1 + CD11b + cells (Supplemental Fig. 1D ). In addition, peritoneal bacteria counts were significantly decreased in the C/EBPb cKO mice vs. control mice (Fig. 1B) . Thus, myeloid-specific C/EBPb deletion protects mice from late sepsis.
To probe mechanisms, we first measured plasma levels of inflammatory cytokines. The early phase of sepsis was characterized by elevated production of proinflammatory cytokines, such as TNF-a and IL-6, whereas late sepsis increased the immunosuppressive cytokines IL-10 and TGF-b [14] . TNF-a and IL-6 levels markedly increased during early sepsis and diminished during late sepsis in both control and C/EBPb cKO mice, but levels were greater in control mice in early sepsis (Fig. 2) . In contrast, both control and cKO mice produced modest amounts of IL-10 and TGF-b during early sepsis, but these antiinflammatory mediators increased significantly during late sepsis in the control mice but diminished in the cKO mice (Fig. 2) . These results implicate myeloid cell C/EBPb in controlling sepsis immunosuppression and mortality.
Myeloid-specific C/EBPb deficiency prevents Gr1 + CD11b + MDSC generation during sepsis
Our previous studies suggested that C/EBPb contributes to MDSC generation and expansion in sepsis by inducing the expression of miR-21 and miR-181b [22] . Thus, we next determined the Gr1 + CD11b + cell numbers in the bone marrow and spleens of sham and septic mice. Confirming our previous findings [14] , the proportion of Gr1 + CD11b + cells in the bone marrow in control mice increased from 21% in sham mice to 38% in early septic mice and reached 82% during late sepsis (Fig. 3A) . Gr1 + CD11b + cell numbers did not increase in the C/EBPb cKO mice during sepsis. We also observed similar patterns of increases in the spleens, but the magnitude was less than in the bone marrow (Fig. 3B ). Gr1 + CD11b + MDSCs include both M-MDSC and granulocytic or PMN-MDSC subsets [32] . Relative changes in each subset differ in various pathologies [33, 34] . We determined numbers of M-MDSCs and PMN-MDSCs during sepsis. In control mice, M-MDSCs proportions significantly increased after sepsis induction and were significantly higher in early, than in late, sepsis (38 and 20%, respectively, of the total Gr1 + CD11b + cell population) (Fig.   3C ). PMN-MDSCs increased modestly (31%) during early sepsis and climbed to 66% in late sepsis. In C/EBPb cKO mice, we did not observe any significant changes in the M-MDSC or Sepsis was induced by CLP using a 23-gauge needle, and mice were given antibiotics (imipenem) with fluid resuscitation, which produced early (defined as d 1-5) and late (d 6 and thereafter) sepsis phases. (A) Kaplan-Meier survival curve. Mortality was monitored for 28 d, and the death (moribundity) was separated into 2 categories: early deaths (those occurring on d 1-5), and late deaths (those occurring on days 6-28). All moribund mice suffered significant weight loss (.30%), hypothermia (,34°C), and loss of righting reflex. The data were collected from 25 mice/group, pooled from 3 experiments. (B) C/EBPb cKO diminishes peritoneal bacteria growth in late septic mice. Mice that were moribund during early sepsis were subjected to peritoneal lavage immediately after killing. A corresponding number of surviving, healthy-appearing mice (Cebpb cKO group) were sacrificed and analyzed at the same time. Data were analyzed by GraphPad Prism version 5.0 and are expressed as means 6 SD of 10 mice/group. (Fig. 3C) , supporting the contention that myeloidspecific C/EBPb deficiency prevents MDSC expansion in sepsis.
PMN-MDSC
Gr1
+ CD11b + cells generated in late sepsis are immature and immunosuppressive CD31 expression marks immature Gr1 + CD11b + cells [14] , and its increase indicates reduced differentiation and maturation in the Gr1 + CD11b + cell population. Figure 4A shows that CD31 + cells in control mice increased from 21% in sham mice to 38% during early sepsis and reached 82% of the total Gr1 + CD11b + cells during late sepsis. In contrast, CD31 + cells did not increase in the C/EBPb cKO mice during sepsis. IL-4Ra was expressed on Gr1 +
CD11b
+ cells and marked their immunosuppressive phenotype [32, 35] . Figure 4B shows that Gr1 + CD11b + cells from early septic control mice included few IL-4Ra + cells, which increased to 47% during late sepsis. To further examine the inflammatory phenotype of the Gr1 + CD11b + cells generated in the C/EBPb cKO mice during sepsis, we measured production of immune effector TNF-a, and immune repressor IL-10 and TGF-b1 by Gr1 + CD11b + cells in ex vivo culture. Gr1 + CD11b + cells from sham or early septic control and C/EBPb cKO mice secreted almost similar amounts of TNF-a, as well as small amounts of IL-10 and TGF-b1 cytokines (Fig. 4C and D) . In late sepsis Gr1 + CD11b + cells from the control mice, TNF-a significantly decreased, whereas IL-10 and TGF-b1 significantly increased, compared with cells from the C/EBPb cKO mice. To further investigate the functional phenotype of Gr1 + CD11b + cells generated in the C/EBPb cKO mice during sepsis, we examined their suppressive effects on antigen-driven proliferation of T cells. Gr1 + CD11b + cells from early septic control or C/EBPb cKO mice cultured with CD4 + T cells isolated from spleens of naive, wild-type mice had no significant effect on T cell proliferation (Fig. 4F) . In contrast, Gr1 + CD11b + cells from late septic control mice significantly inhibited T cell proliferation, whereas cells from C/EBPb cKO mice had no effect. Together, these results show that Gr1 +
+ cells generated in the absence of C/EBPb do not increase expression of IL-10 and TGF-b1 and thus are not immunosuppressive.
C/EBPb deficiency promotes Gr1
+ CD11b + cell differentiation and maturation in sepsis As sepsis progresses from the early to the late phase, numbers of Gr1 + CD11b + cells increases (Fig. 3A) , whereas their differentiation and maturation decrease [14] + CD11b + cells from the control mice that could differentiate into macrophages and dendritic cells, and that decrease became more pronounced in late sepsis cells (Fig. 5A) . We did not observe significant decreases in the differentiation of sepsis Gr1 + CD11b + cells from the C/EBPb cKO mice. We next examined colony formation by Gr1 + CD11b
+ cells in methylcellulose culture. As shown in Fig. 5B, Gr1 + CD11b + cells from the control septic mice cultured with M-CSF and G-CSF generated more monocyte-like and granulocyte-like colonies, respectively, compared with cells from the control sham mice. In addition, early sepsis Gr1 + CD11b + cells generated more monocyte-like colonies than late sepsis cells did in the presence of M-CSF. In contrast, stimulation with G-CSF generated more granulocyte-like colonies from late sepsis Gr1 + CD11b + cells than from early sepsis cells. Colony formation by sepsis Gr1 + CD11b + cells from the C/EBPb cKO mice did not significantly differ from sham cells (Fig. 5B) . These results show that, as the sepsis course progresses from the early to the late phase, the Gr1 + CD11b + cells gain more proliferation capacity with increased potentials toward granulocytic lineage, thus reflecting decreased differentiation and maturation into immunocompetent, innate immune cells.
C/EBPb-deficient Gr1
+ CD11b + cells do not express miR-21 and miR-181b during sepsis Ex vivo knockdown of C/EBPb inhibits expression of miR-21 and miR-181b [22] , which are required to support Gr1 +
CD11b
+ cell generation in septic mice [20] . We next measured miR-21 and miR-181b expressions by real-time PCR. Consistent with our previous observations [20] , expression of miR-21 and miR-181b was induced in bone marrow Gr1 + CD11b + cells during early sepsis and was further increased during late sepsis in the control mice (Fig. 6A) . Most important, miR-21 and miR-181b were not induced in the C/EBPb-deficient Gr1 + CD11b
+ cells, despite that these cells still express Stat3 (data not shown).
Induction of miR-21 and miR-181b expression in Gr1 + CD11b + cells during sepsis prevents their differentiation and maturation [20] . Because Gr1 + CD11b + cells from the C/EBPb knockout mice did not express these miRNAs (Fig. 6A) and could differentiate into macrophages and dendritic cells (Fig. 5A) , we examined whether expressing miR-21 and miR-181b in the C/EBPb-deficient Gr1 + CD11b
+ cells could still affect their differentiation. To test this, we transfected late sepsis Gr1 + CD11b + cells isolated from the bone marrows of C/EBPb cKO mice with miR-21 and miR-181b precursors and measured the miRNA levels and cell differentiation. The levels of miR-21 and miR-181 were increased by more than 2-fold compared with their endogenous levels in late sepsis cells from the control mice (Fig.  6B) . Differentiation of the C/EBPb-deficient cells, which lack the miRNA expression with control miRNA precursor transfection, was significantly greater than C/EBPb-expressing cells from the control mice, which endogenously express miR-21 and miR-181b. Importantly, differentiation of the C/EBPb-deficient cells was significantly reduced when cells were transfected with miRNA precursors (Fig. 6C ). In addition, we observed similar patterns for the miRNA expression and cell differentiation using spleen Gr1 + CD11b + cells (data not shown). These results indicate that C/EBPb deficiency in Gr1 + CD11b + cells prevents the expression (Fig. 4B) , suggesting that they are proinflammatory and immunocompetent. To assess the functional, inflammatory phenotype of these cells in vivo, late sepsis Gr1 + CD11b + cells isolated from the control and C/EBPb cKO mice were adoptively transferred into naive, wild-type mice with CLP, and mortality was assessed for 5 d. Mortality during early sepsis (d 1-5 after CLP) were mainly due to hyperinflammation associated with the production of the proinflammatory TNF-a [14] . For this experiment, mice transferred with Gr1 + CD11b + cells did not receive antibiotic to maximize mortality within this 5-d period. Figure 7A shows that late sepsis C/EBPb-deficient Gr1 + CD11b + cells enhanced mortality. In addition, TNF-a levels significantly increased in mice that received C/EBPb-deficient cells compared with control cells, whereas IL-10 levels were significantly increased in mice that received control, C/EBPbexpressing cells (Fig. 7B) . Thus, C/EBPb-deficient Gr1 + CD11b + cells generated in sepsis do not become immunosuppressive.
DISCUSSION
C/EBPb and another CCAAT/enhancer binding protein C/EBPa regulate various cellular processes related to myelopoiesis [36] , thereby controlling myeloid cell generation and differentiation under normal, steady-state conditions [23] . C/EBPb is required for stress or inflammation-induced myelopoiesis [23] and is often induced by inflammatory mediators, including both anabolic growth factors and immune regulatory cytokines [35, 37] . Our previous report showed that C/EBPb protein is induced in mouse Gr1 + CD11b + cells only after sepsis induction [20] . The present study shows, for the first time to our knowledge, that C/EBPb expression is an essential checkpoint for generating immunosuppressive Gr1 [22] . C/EBPb induction and Stat3 phosphorylation also occurs in "emergency" myelopoiesis [37] . The bone marrow myeloid cell phenotype in the Stat3 cKO mouse [35, 37] is similar to that of the C/EBPb cKO mice in that emergency myelopoiesis and Gr1 + CD11b + cell expansion is impaired. In Figure 7 . Adoptive transfer of late sepsis Gr1 + CD11b + cells from C/EBPb cKO mice into mice undergoing early sepsis enhanced the early proinflammatory responses and increased mortality, whereas cells from the control mice exhibited the opposite effects. Gr1 addition, during the emergency myelopoiesis induced by GM-CSF and G-CSF administration, the number of myeloid progenitors are not increased in the bone marrow of the C/EBPb cKO mice [38] , similar to what we observed in sepsis. Together, these findings further confirm the pivotal role of C/EBPb in promoting inflammation-driven myelopoiesis and in generating Gr1 + CD11b + MDSCs during sepsis. In this study, Gr1 + CD11b + cells isolated from the C/EBPb cKO mice during sepsis did not express miR-21 and miR-181b and were able to differentiate and mature ex vivo. Moreover, transfecting both miRNAs into C/EBPb-deficient cells blocked their differentiation and maturation, further supporting that miR-21 and miR-181b expressions lie distal to C/EBPb as a mechanism for promoting MDSC generation during sepsis. In our previous work [20] , blockade of miR-21 and miR-181b by miRNA antagomir injection during sepsis both diminished MDSC generation and improved survival. Furthermore, MiR-21 and miR-181b contribute to an NFI-A feed-forward loop that maintains the myeloid progenitors in an undifferentiated state by activating NF-kB in Gr1 + CD11b + cells [20, 21] . Inhibition of NFI-A expression leads to normal monocytic and granulocytic differentiation and maturation [39, 40] . Thus, MDSC formation and persistence requires C/EBPb as proximal to a complex signaling pathway of immunosuppression.
MDSCs include both monocyte-like (M-MDSC) and granulocytelike (PMN-MDSC) subsets, which exhibit phenotypic and functional differences, depending on the inflammatory environment or tumor pathology [33, 34] . MDSCs generated in the presence of growing tumors may differ functionally, with PMN-MDSC producing more immunosuppressive mediators than M-MDSCs do [17, 41] . Our results showed that MDSCs generated in control, C/EBPb-expressing mice in early sepsis were predominantly M-MDSCs, whereas late sepsis was associated with significant increases in the PMN-MDSC subset. In line with that, our previous studies [14] and the present study showed that the Gr1 + CD11b
+ cells generated during early sepsis produced more proinflammatory mediators, such as TNF-a and nitric oxide, whereas cells from late septic mice produced more immunosuppressive mediators, such as IL-10 and TGF-b.
This study introduces important, unanswered questions. The incidence of sepsis is increasing, and mortalities are highest during old age [42, 43] . Does C/EBPb similarly control MDSC generation in young vs. older mice? Does the C/EBPb-microRNA axis generate MDSCs in human sepsis? CD8 + T cell exhaustion is a common feature of sepsis immune suppression in mice and humans [1, 44] . Do MDSCs contribute to T cell exhaustion?
In summary, this study shows that myeloid cell C/EBPb has an essential role in generating MDSCs during polymicrobial sepsis in mice and informs a new target for immune enhancement treatment of sepsis. 
